Cargando…

Model difference in the effect of cilostazol on the development of experimental pulmonary hypertension in rats

BACKGROUND: Preventing pulmonary vascular remodeling is a key strategy for pulmonary hypertension (PH). Causes of PH include pulmonary vasoconstriction and inflammation. This study aimed to determine whether cilostazol (CLZ), a phosphodiesterase-3 inhibitor, prevents monocrotaline (MCT)- and chronic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Toshikazu, Zhang, Erquan, Omori, Ayaka, Kabwe, Jane, Kawai, Masako, Maruyama, Junko, Okada, Amphone, Yokochi, Ayumu, Sawada, Hirofumi, Mitani, Yoshihide, Maruyama, Kazuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605570/ https://www.ncbi.nlm.nih.gov/pubmed/34801000 http://dx.doi.org/10.1186/s12890-021-01710-4

Ejemplares similares

Lung damage created by high tidal volume ventilation in rats with monocrotaline-induced pulmonary hypertension
por: Kawai, Masako, et al.
Publicado: (2022)

Thrombomodulin protects against lung damage created by high level of oxygen with large tidal volume mechanical ventilation in rats
por: Iwashita, Yoshiaki, et al.
Publicado: (2014)

CRISPR-mediated Bmpr2 point mutation exacerbates late pulmonary vasculopathy and reduces survival in rats with experimental pulmonary hypertension
por: Kabwe, Jane Chanda, et al.
Publicado: (2022)

A non-selective endothelin receptor antagonist bosentan modulates kinetics of bone marrow-derived cells in ameliorating pulmonary hypertension in mice
por: Kato, Taichi, et al.
Publicado: (2020)

Comparative Transcriptome Analysis Identifies CCDC80 as a Novel Gene Associated with Pulmonary Arterial Hypertension
por: Sasagawa, Shota, et al.
Publicado: (2016)

Potential Contribution of Phenotypically Modulated Smooth Muscle Cells and Related Inflammation in the Development of Experimental Obstructive Pulmonary Vasculopathy in Rats
por: Otsuki, Shoichiro, et al.
Publicado: (2015)

The Isoquinoline-Sulfonamide Compound H-1337 Attenuates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Rats
por: Shoji, Hiroki, et al.
Publicado: (2021)

Alleviation of thalamic pain by cilostazol administration: a case report
por: Haruta‐Tsukamoto, Ayaka, et al.
Publicado: (2018)

Persistent Release of IL-1s from Skin Is Associated with Systemic Cardio-Vascular Disease, Emaciation and Systemic Amyloidosis: The Potential of Anti-IL-1 Therapy for Systemic Inflammatory Diseases
por: Yamanaka, Keiichi, et al.
Publicado: (2014)

Validity and reproducibility of the intake of trans-fatty acids estimated using a FFQ and characteristics of trans-fatty acid intake of the Japanese population: the JPHC FFQ Validation Study
por: Kito, Kumiko, et al.
Publicado: (2023)

Efficacy of cilostazol in canine bradyarrhythmia
por: Ohmori, Takahiro, et al.
Publicado: (2022)

Validity and reliability of a self-administered food frequency questionnaire for the JPHC study: The assessment of amino acid intake
por: Okada, Chika, et al.
Publicado: (2017)

Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis
por: Uchiyama, Shinichiro, et al.
Publicado: (2021)

Final Results of Cilostazol-Aspirin Therapy against Recurrent Stroke with Intracranial Artery Stenosis (CATHARSIS)
por: Uchiyama, Shinichiro, et al.
Publicado: (2015)

Pharmacological Potential of Cilostazol for Alzheimer’s Disease
por: Ono, Kenjiro, et al.
Publicado: (2019)

Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial
por: Hoshino, Haruhiko, et al.
Publicado: (2021)

Safety and efficacy of cilostazol in the management of intermittent claudication
por: Chi, Yung-Wei, et al.
Publicado: (2008)

Cilostazol for the prevention of pneumonia: a systematic review
por: Nakashima, Hirotaka, et al.
Publicado: (2018)

Effects of cilostazol on the heart rate in healthy dogs
por: FUKUSHIMA, Ryuji, et al.
Publicado: (2018)

Effect of Cilostazol on the Pharmacokinetics of Simvastatin in Healthy Subjects
por: Kim, Jung-Ryul, et al.
Publicado: (2019)

Population pharmacodynamics of cilostazol in healthy Korean subjects
por: Jung, Yun Seob, et al.
Publicado: (2018)

Determination of cilostazol and its active metabolite 3,4-dehydro cilostazol from small plasma volume by UPLC−MS/MS
por: Bhatt, Nejal M., et al.
Publicado: (2015)

Cilostazol Inhibits Accumulation of Triglyceride in Aorta and Platelet Aggregation in Cholesterol-Fed Rabbits
por: Ito, Hideki, et al.
Publicado: (2012)

Cilostazol ameliorates diabetic nephropathy by inhibiting high-glucose-induced apoptosis
por: Chian, Chien-Wen, et al.
Publicado: (2020)

Refractory Ileal Perforations in a Cytomegalovirus-Infected Premature Neonate Resolved After Ganciclovir Therapy
por: Morimoto, Mari, et al.
Publicado: (2020)

Cilostazol Add-On Therapy in Patients with Mild Dementia Receiving Donepezil: A Retrospective Study
por: Ihara, Masafumi, et al.
Publicado: (2014)

Management of peripheral arterial disease in the elderly: focus on cilostazol
por: Falconer, Travis M, et al.
Publicado: (2008)

Hemorrhagic Cholecystitis in an Elderly Patient Taking Aspirin and Cilostazol
por: Morris, David S., et al.
Publicado: (2008)

Effect of Cilostazol on the Neuropathies of Streptozotocin-Induced Diabetic Rats
por: Suh, Kwang Sik, et al.
Publicado: (1999)

Allium sativum Compared to Cilostazol as an Inhibitor of Myointimal Hyperplasia
por: Lima, Paulo Roberto da Silva, et al.
Publicado: (2016)

Cardioprotective Effect of Cilostazol on Ischemia-Reperfusion Injury Model
por: Sahin, Mazlum, et al.
Publicado: (2022)

Cilostazol-induced acute tubulointerstitial nephritis accompanied by IgA nephropathy: a case report
por: Shima, Hisato, et al.
Publicado: (2018)

Adjuvant Cardioprotection in Cardiac Surgery: Update
por: Wagner, Robert, et al.
Publicado: (2014)

Efficacy and Safety of Cilostazol in Mild Cognitive Impairment: A Randomized Clinical Trial
por: Saito, Satoshi, et al.
Publicado: (2023)

Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin
por: Araki, Shin-ichi, et al.
Publicado: (2013)

Cilostazol Reduces PAC-1 Expression on Platelets in Ischemic Stroke
por: Lee, Su-Yun, et al.
Publicado: (2008)

Non-occlusive mesenteric ischemia and the role of cilostazol in its management
por: Murthy, K. A. Sudharshana, et al.
Publicado: (2012)

Cilostazol minimizes venous ischemic injury in diabetic and normal rats
por: Wajima, Daisuke, et al.
Publicado: (2011)

Endothelial Dysfunction in the Smokers Can Be Improved with Oral Cilostazol Treatment
por: Kim, Kyu Seop, et al.
Publicado: (2011)

Cilostazol Prevents Endothelin-Induced Smooth Muscle Constriction and Proliferation
por: Kawanabe, Yoshifumi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_puj67s1p0rq5sqapcmsjg7vfbe